UK health body rejects Novartis kidney cancer drug
Reuters The drug, known generically as everolimus, was being considered for the second line treatment of advanced renal cell carcinoma, but the National Institute … |
UK health body rejects Novartis kidney cancer drug
Reuters The drug, known generically as everolimus, was being considered for the second line treatment of advanced renal cell carcinoma, but the National Institute … |